阿托伐他汀联合脂康颗粒对脑梗死二级预防的应用效果  

Application effect of atorvastatin combined with Zhikang granule on secondary prevention of cerebral infarction

作　　者：成笑清 Cheng Xiaoqing(Department of Rehabilitation,the People's Hospital of Taishan City,Guangdong Taishan 529200)

机构地区：[1]台山市人民医院康复科,广东台山529200

出　　处：《中国社区医师》2021年第16期77-78,共2页Chinese Community Doctors

摘　　要：目的:研究阿托伐他汀联合脂康颗粒对脑梗死二级预防的临床效果。方法:2018年7月-2019年6月收治脑梗死患者120例,随机分为两组,各60例。对照组采用阿托伐他汀治疗;观察组给予阿托伐他汀联合脂康颗粒治疗。比较两组治疗效果。结果:观察组甘油三酯、总胆固醇、低密度脂蛋白水平均低于对照组,颈动脉内膜中层厚度小于对照组,脑梗死复发率更低,差异有统计学意义(P<0.05)。结论:联合应用阿托伐他汀和脂康颗粒对脑梗死二级预防有较好的临床效果。Objective:To study the clinical effect of atorvastatin combined with Zhikang granules on secondary prevention of cerebral infarction.Methods:From July 2018 to June 2019,120 patients with cerebral infarction were selected,they were randomly divided into the two groups with 60 cases in each group.The control group was treated with atorvastatin.The observation group was treated with atorvastatin combined with Zhikang granules.We compared the treatment effects of the two groups.Results:The triglyceride,total cholesterol,and low-density lipoprotein levels of the observation group were lower than those of the control group,the carotid artery intima-media thickness was smaller than that of the control group,the recurrence rate of cerebral infarction was lower,the differences were statistically significant(P<0.05).Conclusion:The combined application of atorvastatin and Zhikang granules has a good clinical effect on the secondary prevention of cerebral infarction.

关 键 词：阿托伐他汀 脂康颗粒 脑梗死二级预防 

分 类 号：R743.33[医药卫生—神经病学与精神病学]